1. Home
  2. ATHA vs CETY Comparison

ATHA vs CETY Comparison

Compare ATHA & CETY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATHA
  • CETY
  • Stock Information
  • Founded
  • ATHA 2011
  • CETY 1993
  • Country
  • ATHA United States
  • CETY United States
  • Employees
  • ATHA N/A
  • CETY N/A
  • Industry
  • ATHA Medicinal Chemicals and Botanical Products
  • CETY Power Generation
  • Sector
  • ATHA Health Care
  • CETY Utilities
  • Exchange
  • ATHA Nasdaq
  • CETY Nasdaq
  • Market Cap
  • ATHA 14.8M
  • CETY 14.7M
  • IPO Year
  • ATHA 2020
  • CETY N/A
  • Fundamental
  • Price
  • ATHA $0.40
  • CETY $0.24
  • Analyst Decision
  • ATHA Hold
  • CETY
  • Analyst Count
  • ATHA 3
  • CETY 0
  • Target Price
  • ATHA $0.50
  • CETY N/A
  • AVG Volume (30 Days)
  • ATHA 133.3K
  • CETY 619.3K
  • Earning Date
  • ATHA 08-07-2025
  • CETY 08-19-2025
  • Dividend Yield
  • ATHA N/A
  • CETY N/A
  • EPS Growth
  • ATHA N/A
  • CETY N/A
  • EPS
  • ATHA N/A
  • CETY N/A
  • Revenue
  • ATHA N/A
  • CETY $1,743,723.00
  • Revenue This Year
  • ATHA N/A
  • CETY N/A
  • Revenue Next Year
  • ATHA N/A
  • CETY N/A
  • P/E Ratio
  • ATHA N/A
  • CETY N/A
  • Revenue Growth
  • ATHA N/A
  • CETY N/A
  • 52 Week Low
  • ATHA $0.22
  • CETY $0.20
  • 52 Week High
  • ATHA $3.51
  • CETY $1.27
  • Technical
  • Relative Strength Index (RSI)
  • ATHA 53.29
  • CETY 47.48
  • Support Level
  • ATHA $0.38
  • CETY $0.23
  • Resistance Level
  • ATHA $0.41
  • CETY $0.27
  • Average True Range (ATR)
  • ATHA 0.02
  • CETY 0.02
  • MACD
  • ATHA -0.00
  • CETY -0.00
  • Stochastic Oscillator
  • ATHA 71.70
  • CETY 12.79

About ATHA Athira Pharma Inc.

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.

About CETY Clean Energy Technologies Inc.

Clean Energy Technologies Inc is clean energy and environmentally sustainable technologies company offering heat recovery solutions products. In addition, it also provides engineering and manufacturing solutions focused on other energy-efficient and environmentally sustainable technologies. The company's principal product is the Clean Cycle generator, offered by Heat Recovery Solutions. The company's engineering and manufacturing resources support its heat recovery solutions business. It has four segments: Clean Energy HRS & CETY Europe, CETY Renewables Waste to Energy Solutions, Engineering and Manufacturing Business and CETY HK. It serves various markets, including industrial, aerospace, military, instrumentation, and medical.

Share on Social Networks: